SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-19-001608
Filing Date
2019-01-24
Accepted
2019-01-24 19:44:56
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 5308
  Complete submission text file 0001567619-19-001608.txt   7031
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address
Yea Christopher (Reporting) CIK: 0001691102 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36830 | Film No.: 19540994